Eli Lilly drug gets new approval for blood cancer

Eli Lilly and Company's drug Jaypirca has been granted FDA approval for the treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma in patients.

Related Keywords

Jacob Van Naarden ,Eli Lilly ,Fda ,Jaypirca ,Wall ,Btk Inhibitor ,Bcl 2 Inhibitor ,Bruin Trial ,Loxo Lilly ,Pthe Fda ,